<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="decrease">
            <roleset id="decrease.02" name="" wordnet="1">
                <roles>
                    <role n="0" descr="theme&#x0A;" />
                    <role n="2" descr="amount decreased &#x09;&#x09;&#x09;&#x0A;" />
                    <role n="1" descr="location&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>Concomitantly, acetycoline levels decreases by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>Concomitantly, acetylcholine levels would have decreased by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>In addition, CD3 expression? is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>In addition, CD3? expression has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>In addition, the CD3 expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent (Fig.2B) way.</text>
                </example>
                <example src="EGRAM" no="5">
                    <text>In addition, the CD3? expression is decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="6">
                    <text>In addition, the expression of CD3? is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>In contrast, GP was decreased by the reduction of only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>In contrast, PG decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>In contrast, PG is found to decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) A1 (in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Instead, GP would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>By contrast, GP is predicted that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>By contrast, PG is able to decrease only by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>By contrast, PG is predicted that only decreased by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>In addition, CD3 expression is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>In addition, CD3 expression would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>In addition, CD3 expression? could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>In addition, CD3 expression? is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>In addition, CD3? is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>In addition, CD3? may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>In addition, the expression CD3? expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>In addition, the expression of CD3 expression will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>In addition, the expression of CD3 expression? will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>In contrast, G showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>In contrast, G was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>In contrast, G will only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>In contrast, GP decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>In contrast, GP is predicted that only decreased in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>In contrast, GP may have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>In contrast, GP showed that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>In contrast, GP showed that only decreased by in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>In contrast, GP showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>In contrast, GP was decreased by the reduction of only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>In contrast, GP was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>In contrast, GP will decrease only only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>In contrast, GP would only decrease only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>In contrast, PG is predicted that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>In contrast, PG may have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>In contrast, PG showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>In contrast, PG was decreased by the reduction of only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>In contrast, PG was decreased by the reduction of only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>In contrast, PG was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>In contrast, PG was predicted for only decreased in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>In contrast, PG will decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>In contrast, PG will decrease only only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>In contrast, PG would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>In contrast, PG would only decrease only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>Instead, GP would only decrease only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>Instead, PG decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>Instead, PG decreased a reduction in only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Instead, PG would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>Instead, PG would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>Instead, PG would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>By contrast, acetylcholine levels is able to decrease only by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>By contrast, acetylcholine levels is predicted that only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>In addition, GP could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>In addition, acetycoline levels could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>In addition, acetycoline levels is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>In addition, acetylcholine levels may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>In addition, acetylcholine levels will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>In addition, the expression GP was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>In addition, the expression acetycoline levels was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>In contrast, acetycoline levels is predicted that only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>In contrast, acetycoline levels may decrease only only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>In contrast, acetycoline levels was demonstrated by only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>In contrast, acetycoline levels was demonstrated by only decreased by lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>In contrast, acetycoline levels was demonstrated by only decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>In contrast, acetycoline levels was predicted for only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>In contrast, acetycoline levels will decrease only only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>In contrast, acetylcholine levels could decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>In contrast, acetylcholine levels showed that only decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>In contrast, acetylcholine levels was predicted for only decreased in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>In contrast, acetylcholine levels will only decrease only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>In contrast, acetylcholine levels would only decrease only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Instead, acetycoline levels decreased a reduction in only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Instead, acetycoline levels decreased a reduction in only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Instead, acetycoline levels would only decrease only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Instead, acetylcholine levels would only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
